It is often difficult to clinically distinguish between Legionella pneumophila and Streptococcus pneumoniae. In Europe, the incidence rate for Legionella infections has been on the rise for the past several years, with 8% of cases resulting in death" 1. Streptococcus pneumoniae is the leading cause of community-acquired pneumonia with an incidence estimated at 1 per 1000 adults per year.2 Tru Legionella® and Tru Strep pneumo™ provide healthcare systems an opportunity to improve patient outcomes and antibiotic stewardship by accurately detecting Legionella pneumophila or Streptococcus pneumoniae. • In just minutes, the Tru® technology can detect Legionella pneumophila serogroup 1 antigen in urine or Streptococcus pneumoniae infection from urine and CSF samples • Improve lab workflow with a unique, closed system - one sample, two tests, same platform • Fast, accurate, actionable results enable physicians to make informed decisions about the management and treatment of their patients Improve outcomes for patients with results that count • How would a rapid diagnostic test that enables the use of appropriate antibiotic therapy for bacterial pneumonias improve physician and patient satisfaction? • How would easy-to-use tests with just 3 steps improve your laboratory workflow?

Total Trusted Solution • Urinary antigen testing for Streptococcus pneumoniae is recommended by ESCMID and ERS3,4 • The most commonly used method to diagnose Legionnaires’ disease is the detection of antigen in a urine specimen during the acute phase of the illness5 • The Tru technology is a closed system which helps protects against potential cross contamination in the lab • Standardized testing with a simplified procedure assures reliable results Tru Legionella® / Tru Strep Pneumo™ procedure One sample, two tests, same platform Sample to result in 3 steps Tru Legionella® - rapid qualitative...